Literature DB >> 13334809

Prophylaxis of isoniazid neuropathy with pyridoxine.

H B CARLSON, E M ANTHONY, W F RUSSELL, G MIDDLEBROOK.   

Abstract

Entities:  

Keywords:  NERVOUS SYSTEM/diseases; NICOTINIC ACID ISOMERS/injurious effects; VITAMIN B0/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13334809

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.

Authors:  Christopher Trent Brewer; Lei Yang; Anne Edwards; Yan Lu; Jonathan Low; Jing Wu; Richard E Lee; Taosheng Chen
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

2.  Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.

Authors:  W MANDEL; A D HEATON; W F RUSSELL; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

3.  Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.

Authors:  W F RUSSELL; I KASS; A D HEATON; S H DRESSLER; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

4.  [Vitamin B6 deficiency and urinary excretion of xanthurenic acid and other tryptophan metabolites in sick persons. II. Influence of isonicotinic acid hydrazide on vitamin B6 metabolism and vitamin B6 deficiency conditions in pregnant persons].

Authors:  A KNAPP; B GASSMANN; W ZIMMERMANN
Journal:  Klin Wochenschr       Date:  1958-09-01

5.  Isonicotinic acid hydrazide-induced spongy degeneration of the white matter in the brains of Pekin ducks.

Authors:  W W Carlton; G Kreutzberg
Journal:  Am J Pathol       Date:  1966-01       Impact factor: 4.307

Review 6.  Genetic Variants and Drug Efficacy in Tuberculosis: A Step toward Personalized Therapy.

Authors:  Almas Khan; Mohammad Abbas; Sushma Verma; Shrikant Verma; Aliya Abbas Rizvi; Fareya Haider; Syed Tasleem Raza; Farzana Mahdi
Journal:  Glob Med Genet       Date:  2022-02-25

Review 7.  Isoniazid metabolism and hepatotoxicity.

Authors:  Pengcheng Wang; Komal Pradhan; Xiao-Bo Zhong; Xiaochao Ma
Journal:  Acta Pharm Sin B       Date:  2016-08-03       Impact factor: 11.413

8.  Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India.

Authors:  Faisal Imam; Manju Sharma; Khalid Umer Khayyam; Mohammad Rashid Khan; Mohammad Daud Ali; Wajhul Qamar
Journal:  Saudi Pharm J       Date:  2020-04-19       Impact factor: 4.330

9.  Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid.

Authors:  Christopher Trent Brewer; Kiran Kodali; Jing Wu; Timothy I Shaw; Junmin Peng; Taosheng Chen
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

10.  Neuromyelitis optica spectrum disorder and active tuberculosis.

Authors:  James Kerr Grieve; Scott Day; David Connell; Jonathan O'Riordan
Journal:  BMJ Case Rep       Date:  2020-01-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.